Study of the improvement effect of the Maintenance treatment of Vonoprazan and Esomeprazole on symptoms in patients with gastro-esophageal reflux disease (GERD)
- Conditions
- gastro-esophageal reflux disease (GERD)
- Registration Number
- JPRN-UMIN000032495
- Lead Sponsor
- Suita municipal hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Not provided
1)Patients with warning signs such as vomiting, gastrointestinal bleeding (including findings of hematemesis, melena, and anemia),and sudden weight loss 2)Patients with a confirmed, or suspected, malignant lesion 3)Patients with a history of gastrointestinal resection or vagotomy 4)The patient with Irritable Bowel Syndrome (IBS) 5)Patients whose participation in this study would be contraindicated due to complications such as serious hepatic disease, renal disease, or cardiac disease. 6)Women who are pregnant or who may possibly be pregnant, and lactating mothers 7)treated with atazanavir sulfate, Rilpivirine Hydrochloride 8)Other patients whom the investigator considers unsuitable for admission to the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method